Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613000856718Phase 4Recruiting
Phase 4, randomised trial in major depressive disorder (MDD) comparing Metformin with Placebo (2 arms). Primary endpoint: Severity of depression. Started Jun 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613000856718.